Literature DB >> 34992991

Myelopathy Because of CAR-T-Related Neurotoxicity Treated With Siltuximab.

Yasmin Aghajan1, Alison Yu1, Caron A Jacobson1, Austin I Kim1, Leslie Kean1, Matthew Robertson1, Henrikas Vaitkevicius1.   

Abstract

Entities:  

Year:  2021        PMID: 34992991      PMCID: PMC8723956          DOI: 10.1212/CPJ.0000000000001078

Source DB:  PubMed          Journal:  Neurol Clin Pract        ISSN: 2163-0402


× No keyword cloud information.
  4 in total

1.  Neurological toxicities associated with chimeric antigen receptor T-cell therapy.

Authors:  Daniel B Rubin; Husain H Danish; Ali Basil Ali; Karen Li; Sarah LaRose; Andrew D Monk; David J Cote; Lauren Spendley; Angela H Kim; Matthew S Robertson; Matthew Torre; Timothy R Smith; Saef Izzy; Caron A Jacobson; Jong Woo Lee; Henrikas Vaitkevicius
Journal:  Brain       Date:  2019-05-01       Impact factor: 13.501

2.  Endothelial Activation and Blood-Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells.

Authors:  Juliane Gust; Kevin A Hay; Laïla-Aïcha Hanafi; Daniel Li; David Myerson; Luis F Gonzalez-Cuyar; Cecilia Yeung; W Conrad Liles; Mark Wurfel; Jose A Lopez; Junmei Chen; Dominic Chung; Susanna Harju-Baker; Tahsin Özpolat; Kathleen R Fink; Stanley R Riddell; David G Maloney; Cameron J Turtle
Journal:  Cancer Discov       Date:  2017-10-12       Impact factor: 39.397

3.  Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas.

Authors:  Stephen J Schuster; Jakub Svoboda; Elise A Chong; Sunita D Nasta; Anthony R Mato; Özlem Anak; Jennifer L Brogdon; Iulian Pruteanu-Malinici; Vijay Bhoj; Daniel Landsburg; Mariusz Wasik; Bruce L Levine; Simon F Lacey; Jan J Melenhorst; David L Porter; Carl H June
Journal:  N Engl J Med       Date:  2017-12-10       Impact factor: 91.245

Review 4.  Chimeric antigen receptor T-cell therapies for lymphoma.

Authors:  Jennifer N Brudno; James N Kochenderfer
Journal:  Nat Rev Clin Oncol       Date:  2017-08-31       Impact factor: 66.675

  4 in total
  1 in total

1.  Extensive myelitis with eosinophilic meningitis after Chimeric antigen receptor T cells therapy.

Authors:  Baptiste Le Calvez; Marion Eveillard; Paul Decamps; Jesus Aguilar; Amélie Seguin; Emmanuel Canet; Audrey Grain; Cyrille Touzeau; Benoît Tessoulin; Thomas Gastinne
Journal:  EJHaem       Date:  2022-02-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.